Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients

Figure 3

Cumulative Kaplan-Meier curves of the effect of Her4 (JM-a) and ER expression on EFS and OS of Her2 positive patients. Panels A and B: EFS and OS of Her2 positive Her4/ER subcollectives are shown. Panels C – F: Kaplan-Meier analyses of the effect of differentially classified Her4 (JM-a) and ER expression on EFS (C and E) and OS (D and F) of Her2 positive patients.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us